| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c02ce3b180731fc802bd1dee84d487fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_153ac9c2c8a4783bf058e768de0a219c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9735c148c3ff0ee9ecf7b3010cdd5d0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ec120b0d8fcb326ac36223123cb0d26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb721057cd8e010f5fe6aa37050b76d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5f2722034024fbff2ffcc4e20b8e1b1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-131
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-131
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01F3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-08 |
| filingDate |
2006-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52e1e99ff7cf4f4fe2f7447818232dc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b17e190f648d2a416c096494bb8fef48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d2bcea6219cf300f0490945c760b575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c7a55a6c0a0abe7257dd123582c1ee6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_390253dc5a4f700871a43a52ba7f7cb2 |
| publicationDate |
2008-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008082321-A1 |
| titleOfInvention |
Emulsion of perfluoroorganic compounds for medical use and a methods for the preparation and the use thereof |
| abstract |
The invention relates to biomedicine. The inventive emulsion of perfluoroorganic compounds, which is used for intravascular or local injection, comprises a rapidly eliminated perfluor carbon-perfluor decalin, a low eliminated perfluorinated tertiary amine of perfluor-N-(4-methyl-cyclohexyl)-piperidine and a physiologically acceptable salt-aqueous solution. The critical solution temperatures of all components of the perfluoroorganic compounds dissolved in hexane (TcrH) differ from each other at a value which is equal to or less than 2-4°C, thereby increasing the stability of the emulsions of perfluoroorganic compound. The emulsion ofperfluoroorganic compounds is stabilised by a mixture of polyoxyethylene-polyoxypropylene block copolymers and comprises only the entirely fluorinated impurities of the perfluoroorganic compounds, thereby reducing the toxicity thereof. The inventive emulsion producing method consists in mixing and dispersing the mixture of liquid perfluoroorganic compounds with the aqueous solution of a stabilising agent and in subsequently reducing it in a high pressure homogeniser in such a way that submicron emulsion particles are obtained. The inventive method for treating the blood system diseases consists in injecting the perfluoroorganic compound emulsion into the blood current or into a lymphatic channel. |
| priorityDate |
2006-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |